Brief: scPharmaceuticals Q1 Revenue USD 6.102 Million Vs. IBES Estimate USD 5.98 Million
May 14 (Reuters) - scPharmaceuticals Q1 operating expenses USD 21.958 million. * Q1 income from operations USD -15.856 million vs. IBES estimate USD -16.1 million * Q1 net income USD -14.108 million vs. IBES estimate USD -17.4 million * Q1 basic EPS USD -0.36